Camlin Fine Sciences
204.15
-10.75(-5.00%)
Market Cap₹4,038.40 Cr
PE Ratio65.68
IndustryChemicals
Company Performance:
1D-5.00%
1M-30.50%
6M+44.46%
1Y+102.79%
5Y+127.24%
View Company Insightsright
Latest news about Camlin Fine Sciences
Camlin Fine Sciences Reports Narrowed Q1 Loss Despite Revenue Dip 4 days ago
Camlin Fine Sciences reported a consolidated net loss of 100 million rupees in Q1, down from 340 million rupees last year, despite revenue falling to 4,236 million rupees from 4,375 million rupees. The Specialty Ingredients (Value-added Blends) segment showed strong growth, while other segments experienced declines. EBITDA decreased to 190 million rupees, with the margin contracting to 4.49%. Regional performance varied, with Mexico and Europe showing growth. The company is focusing on high-value blends and additives, developing new downstream products, and enhancing its naturals and emulsifiers portfolio.
Camlin Fine Sciences Reports Improved Q4 EBITDA and Margin, Narrows Losses May 23, 2025
Camlin Fine Sciences to Expand Portfolio with Majority Stake Acquisition in Vinpai Feb 27, 2025
Camlin Fine Sciences to Acquire Up to 100% Stake in French Ingredient-Tech Company Vinpai S.A. Feb 25, 2025